Snowden Capital Advisors LLC Acquires 164 Shares of Chemed Co. (NYSE:CHE)

Snowden Capital Advisors LLC raised its holdings in shares of Chemed Co. (NYSE:CHE) by 17.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,105 shares of the company’s stock after acquiring an additional 164 shares during the period. Snowden Capital Advisors LLC’s holdings in Chemed were worth $585,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of CHE. Hennion & Walsh Asset Management Inc. grew its position in Chemed by 72.5% during the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 840 shares of the company’s stock valued at $445,000 after acquiring an additional 353 shares during the last quarter. Trust Co. of Vermont bought a new position in shares of Chemed in the fourth quarter worth approximately $34,000. UMB Bank n.a. grew its holdings in shares of Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after purchasing an additional 39 shares during the last quarter. Ballentine Partners LLC grew its holdings in shares of Chemed by 7.5% in the fourth quarter. Ballentine Partners LLC now owns 704 shares of the company’s stock worth $373,000 after purchasing an additional 49 shares during the last quarter. Finally, Mitchell & Pahl Private Wealth LLC grew its holdings in shares of Chemed by 10.5% in the fourth quarter. Mitchell & Pahl Private Wealth LLC now owns 1,198 shares of the company’s stock worth $635,000 after purchasing an additional 114 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors.

Chemed Stock Performance

Shares of Chemed stock opened at $580.49 on Wednesday. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $623.61. The stock has a market capitalization of $8.49 billion, a price-to-earnings ratio of 29.33, a P/E/G ratio of 2.15 and a beta of 0.59. The company’s 50 day moving average price is $585.81 and its 200-day moving average price is $564.80.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, beating the consensus estimate of $5.59 by $0.04. The business had revenue of $646.94 million for the quarter, compared to analysts’ expectations of $641.78 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.20 earnings per share. As a group, equities research analysts forecast that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend is Thursday, May 29th. Chemed’s dividend payout ratio (DPR) is currently 9.74%.

Analyst Upgrades and Downgrades

CHE has been the topic of several recent analyst reports. Royal Bank of Canada raised their target price on shares of Chemed from $667.00 to $674.00 and gave the stock an “outperform” rating in a report on Monday, April 28th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

Insider Activity at Chemed

In other Chemed news, EVP Spencer S. Lee sold 1,500 shares of the firm’s stock in a transaction on Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total transaction of $866,790.00. Following the completion of the transaction, the executive vice president now owns 16,127 shares of the company’s stock, valued at approximately $9,319,148.22. This trade represents a 8.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the firm’s stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares of the company’s stock, valued at $62,566,139.07. This represents a 0.97% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,500 shares of company stock worth $4,401,120 over the last quarter. Corporate insiders own 3.29% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.